Herpes treatment advances - not directly MS related

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
rainer
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 3:00 pm

Herpes treatment advances - not directly MS related

Post by rainer »

Was poking around for info last night and found a few interesting things... none of this is breaking news or anything.

Bayer AG - research - Herpes virus is a pdf of Bayer's report on developing Herpes treatments. Obviously it is heavily biased and is probably a few years old but still quite informative. For instance: two different versions of the virus hide away in the body, one typically in the inner ear/temple part of the brain and one in the spine. (sound a bit like rrms and ppms to anyone else?)

Bayer apparently broke off their anti-viral research into it's own company: Aicuris who is developing the drug BAY 57-1293 which is dramatically more effective at treating herpes then the current anti-virals used. They are said to be moving forth into human trials soon (I've read their lead compound is in Phase 2 but am not sure if that is BAY 57-1293).

None of that is directly related to MS research, but if there is a connection and if the current anti-virals just weren't enough to touch MS... BAY 57-1293 is worth keeping an eye on.
Post Reply

Return to “Drug Pipeline”